Recent

% | $
Quotes you view appear here for quick access.

Seattle Genetics, Inc. Message Board

  • clearstone72 clearstone72 Nov 13, 2013 2:04 PM Flag

    PCYC's new Lymphoma Drug fast-track approved by FDA

    This is having a collateral effect on other biotechs today. Given that PCYC is the only bigger holding in Baker Bros portfolio than SGEN and the newly approved drug also is now an approved drug for a derivative form of lymphoma, any thoughts on longer term impact on SGEN? For Example: Would J&J and PCYC license SGEN ADC tech to improve targeting via Bakers' influence?

 
SGEN
45.58+0.22(+0.49%)12:24 PMEDT